Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Policy / Pricing
  • AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies
  • Policy / Pricing

AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies

BioSpace

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie's deal with the White House to avoid tariffs.

Policy / PricingImmunology & InflammationRead full story

pharminent April 7, 2026 (Last updated: April 7, 2026)

BioSpace

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie’s deal with the White House to avoid tariffs.

Policy / PricingImmunology & InflammationRead full story

Post navigation

Previous: Kennedy changes vaccine panel charter after legal setback
Next: Gilead strikes again, penning $5bn deal to buy Tubulis

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.